9814
Comment:
|
9877
|
Deletions are marked like this. | Additions are marked like this. |
Line 5: | Line 5: |
||<style="text-align:center;">{{attachment:nrc.png||width=150}}||[[ https://nrc.canada.ca/en |National Research Council Canada]]||AI for Precision Discovery on Associations in Biological Systems <<BR>><<BR>>Pl: Xiaojian Shao, Youlian Pan ||2020-2021|| ||<style="text-align:center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||A reference cell atlas of human liver diversity of a lifespan ||2019-2021|| |
||<style="text-align:center;">{{attachment:nrc.png||width=150}}||[[ https://nrc.canada.ca/en |National Research Council Canada]]||AI for Precision Discovery on Associations in Biological Systems <<BR>><<BR>>Spon Ref: AI4D-109-1<<BR>><<BR>>Pl: Xiaojian Shao, Youlian Pan ||2020-2021|| ||<style="text-align:center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||A reference cell atlas of human liver diversity of a lifespan <<BR>><<BR>> PI: Alan Mullen ||2019-2021|| |
Funding Agency |
Title |
Grant Period |
|
Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes |
2020-2021 |
||
AI for Precision Discovery on Associations in Biological Systems |
2020-2021 |
||
A reference cell atlas of human liver diversity of a lifespan |
2019-2021 |
||
Stem cell based approaches to endogenous repair of brain and skeletal muscle |
2019-2020 |
||
Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart |
2019-2020 |
||
Development of novel cell and tissue therapies to treat liver failure |
2019-2020 |
||
Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) |
2017-2021 |
||
Acute Leukemia Translational Initiative (Operating Grant) |
2017-2021 |
||
The Cancer Genome Collaboratory |
2016-2022 |
||
Cell and tissue communication networks |
2016-2021 |
||
Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). |
2016-2019 |
||
Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). |
2016-2019 |
||
Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). |
2016-2019 |
||
From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) |
2015-2022 |
||
Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) |
2015-2020 |
||
A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). |
2015-2018 |
||
Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) |
2015-2019 |
||
The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) |
2014-2018 |
||
Cancer stem cell program (Operating Grant) |
2013-2017 |
||
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) |
2013-2017 |
||
National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. |
2012-2017 |
||
U.S. NIH via National Institute of General Medical Sciences (NIGMS) |
Cytoscape: A Modeling Platform for Biomolecular Networks |
2009-2017 |
|
U.S. NIH via National Human Genome Research Institute (NHGRI) |
Pathway Commons Research resource for biological pathways. |
2008-2018 |
|
A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) |
2007-2017 |
||
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) |
2006-2017 |